Objective: This study examined the incidence of and healthcare costs attributable to genital
warts within a large US commercially insured, geographically dispersed population …

Background Medical therapy for genital warts remains suboptimal. The topical interferon and
cytokine inducer, imiquimod, has been proved effective for the treatment of external genital …

With the licensing of the new drug Imiquimod cream 5%(AldaraTM 3M Health Care) for the
treatment of anogenital warts and its inclusion into clinic guidelines, a case note review audit …

Objective. To evaluate if new imiquimod formulations using a shorter treatment duration are
safe and efficacious to treat anogenital warts. Methods. In two studies 534 women≥ 12 …

Background Interferon has been widely used in the treatment of genital warts for its
immunomodulatory, antiproliferative and antiviral properties. Currently, no evidence that …

A model was developed to estimate the cost-effectiveness of podophyllotoxin and imiquimod
for self-treatment of anogenital warts. The effectiveness endpoint was sustained clearance …

Objective: The objective of this randomized, double-blind, placebo-controlled trial was to
evaluate the mechanism of action of imiquimod cream in the treatment of anogenital warts …

Results We found 12 systematic reviews, RCTs, or observational studies that met our
inclusion criteria. We performed a GRADE evaluation of the quality of evidence for …

Background: Nongenital warts are a common condition seen in general practice, affecting
patients of all ages. There are many treatment options and patients often self medicate with …

External anogenital warts, or condylomata acuminata, are caused by the proliferation of
squamous epithelial cells secondary to human papillomavirus infection. In sexually active …